Lumiera Health Inc.
NHPHF
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 60.90K | 68.80K | 50.80K | 141.10K | 96.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.90K | 68.80K | 50.80K | 141.10K | 96.30K |
| Cost of Revenue | 43.80K | 46.50K | 7.90K | 182.00K | 58.70K |
| Gross Profit | 17.10K | 22.30K | 42.90K | -40.80K | 37.60K |
| SG&A Expenses | 50.60K | 54.70K | 45.80K | 249.50K | 223.00K |
| Depreciation & Amortization | 2.70K | 2.70K | 2.70K | 15.80K | 16.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 97.10K | 103.90K | 56.40K | 447.20K | 298.10K |
| Operating Income | -36.20K | -35.10K | -5.60K | -306.10K | -201.80K |
| Income Before Tax | -105.10K | -106.40K | -61.60K | -1.01M | -354.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -105.10K | -106.40K | -61.60K | -1.01M | -354.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -105.10K | -106.40K | -61.60K | -1.01M | -354.70K |
| EBIT | -36.20K | -35.10K | -5.60K | -306.10K | -201.80K |
| EBITDA | -33.50K | -32.40K | -2.90K | -290.30K | -185.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 169.97M | 169.97M | 169.97M | 169.97M | 169.97M |
| Average Diluted Shares Outstanding | 169.97M | 169.97M | 169.97M | 169.97M | 169.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
